MedTrace Logo

Immunophenotype of Risk in Older Patients Admitted for Pneumonia

NCT04062799 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 174

Last updated 2021-11-23

No results posted yet for this study

Summary

The objective is to evaluate if the immune risk phenotype (IRP) in patients who have been admitted for pneumonia predisposes to worse long-term outcomes. In addition, the association between the detected immunological alterations and clinical, functional, nutritional or comorbidity risk factors will be evaluated.

If the hypothesis is confirmed, helpful immunological markers will be identified. This will be useful in clinical practice to identify patients who can benefit from an intervention and / or to identify the best time for vaccination. Otherwise, valuable information will be obtained on the interrelation between immunological, clinical, functional and nutritional aspects.

Conditions

  • Age Associated Immune Deficiency
  • Elderly Infection
  • Pneumonia
  • Nutrition Disorders in Old Age
  • Frail Elderly Syndrome
  • Sarcopenia

Interventions

OTHER

no intervention

It is an observationa study. There is no intervention.

Sponsors & Collaborators

  • Fondo de Investigacion Sanitaria

    collaborator OTHER

  • Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

    lead OTHER

Principal Investigators

  • Olga H Torres, PhD MD · Hospital de Sant Pau. Universitat Autònoma de Barcelona. Institut de Recerca Sant Pau.

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-09
Primary Completion
2023-07-31
Completion
2024-01-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04062799 on ClinicalTrials.gov